ADVIA Centaur eE2Recalls & reported problems across all models

We found 3 models of ADVIA Centaur eE2 by Siemens Healthcare Diagnostics Inc. in the FDA's device registry (GUDID). Together they are named in 22 adverse event reports in the FDA's MAUDE database, received between Jul 7, 2017 and Jul 4, 2025 — classified as 3 injuries, 19 malfunctions.

The most frequently reported specific device problem is “High Test Results” (4 reports).

3 FDA recall records name at least one of these models by its device identifier, 3 still open.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event. Widely used products collect more reports, so totals can't be used to compare products or estimate failure rates. Only reports that name a model's exact device identifier are counted. What reports can and can't tell you · How this data works

ADVIA Centaur eE2 recalls

FDA recall records that name at least one of these models by its device identifier, newest first. Each recall usually covers specific models or lots, so check the details.

1. Mar 3, 2022Open, Classified

   Falsely Elevated Results Observed with Plasma Specimens, could lead a clinician to misinterpret patient results

   Z-1025-2022 · Root cause: Under Investigation by firm · Recall details · FDA record ↗

2. Mar 3, 2022Open, Classified

   Falsely Elevated Results Observed with Plasma Specimens, could lead a clinician to misinterpret patient results

   Z-1024-2022 · Root cause: Under Investigation by firm · Recall details · FDA record ↗

3. Mar 3, 2022Open, Classified

   Falsely Elevated Results Observed with Plasma Specimens, could lead a clinician to misinterpret patient results

   Z-1023-2022 · Root cause: Under Investigation by firm · Recall details · FDA record ↗

Most reported ADVIA Centaur eE2 problems

ADVIA Centaur eE2 models

3 models, most reported first. Each model has its own page with its reports, recalls and device details.

• ADVIA Centaur® eE2 10491445

  RADIOIMMUNOASSAY, ESTRADIOL
  1 recall14 reports
• ADVIA Centaur® eE2 10490889

  RADIOIMMUNOASSAY, ESTRADIOL
  1 recall8 reports
• ADVIA Centaur® eE2 10697757

  RADIOIMMUNOASSAY, ESTRADIOL
  1 recall0 reports

Recent ADVIA Centaur eE2 adverse event reports

The 15 most recent reports across all models, in the reporter's own words as published by the FDA.

• MalfunctionJul 4, 2025High Test Results; High Test Results

  THE CUSTOMER REPORTED OBSERVATION OF ELEVATED ADVIA CENTAUR ENHANCED ESTRADIOL (EE2) RESULTS WHICH WERE DISCORDANT RELATIVE TO REPEAT TESTING ON AN ALTERNATE METHOD WHEN USING LOT 104. AN INITIAL ELEVATED RESULT WAS OBTAINED FOR ONE (1) PATIENT SAMPLE. THE INITIAL ELEVATED RESULT WAS REPORTED TO THE PHYSICIAN WHO QUESTIONED THE RESULT. THE SAME SAMPLE WAS RETESTED ON THE ORIGINAL ANALYZER WHICH PRODUCED A SIMILAR ELEVATED RESULT. FOR TROUBLESHOOTING PURPOSES, THE SAME SAMPLE WAS TREATED WITH PEG (POLYETHYLENE GLYCOL 6000) AND RETESTED ON THE ORIGINAL ANALYZER WHICH PRODUCED A LOWER RESULT. THE SAMPLE WAS THEN TESTED ON AN ALTERNATE METHOD WHICH OBTAINED A LOWER RESULT. THIS LOWER RESULT WAS CONSIDERED CORRECT SINCE IT MATCHED THE CLINICAL PICTURE OF THE PATIENT AND WAS ISSUED ON THE CORRECTED REPORT TO THE PHYSICIAN. THERE ARE NO ALLEGATIONS OF PATIENT HARM, CHANGES IN TREATMENT, OR DELAYS OF DIAGNOSIS OR TREATMENT RESULTING FROM THE OBSERVED RESULT DISCORDANCE.

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 22402685 ↗
• MalfunctionMar 1, 2023High Test Results; High Test Results

  THE CUSTOMER REPORTS OBSERVATION OF ELEVATED ADVIA CENTAUR XP ENHANCED ESTRADIOL (EE2) RESULTS WHICH WERE DISCORDANT RELATIVE TO ALTERNATE-METHOD TESTING. PRODUCT LOT USED AND DETAILS OF TESTING WERE NOT PROVIDED. THERE ARE NO REPORTS THAT TREATMENT WAS ALTERED OR PRESCRIBED OR ADVERSE HEALTH CONSEQUENCES DUE TO THE DISCORDANT ADVIA CENTAUR XP ENHANCED ESTRADIOL (EE2) RESULTS.

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 16461620 ↗
• MalfunctionJul 15, 2021High Test Results; High Test Results

  DISCORDANT, FALSELY ELEVATED ADVIA CENTAUR XP ENHANCED ESTRADIOL (EE2) NEAT (UNDILUTED) AND ONBOARD (AUTO) DILUTION RESULTS WERE OBTAINED ON A PATIENT SAMPLE. THE ELEVATED RESULTS WERE NOT REPORTED TO THE PHYSICIAN(S). THE CUSTOMER PERFORMED REPEAT TESTING ON THREE ALTERNATE ESTRADIOL TEST METHODS WITH THE SAME PATIENT SAMPLE (NEAT), ALL RESULTING LOWER. THE LOWER ALTERNATE ESTRADIOL TEST RESULTS AGREED WITH THE CLINICAL PICTURE OF THIS PATIENT. THE LOWER ESTRADIOL RESULT WAS REPORTED TO THE PHYSICIAN(S). THERE ARE NO REPORTS THAT TREATMENT WAS ALTERED OR PRESCRIBED OR ADVERSE HEALTH CONSEQUENCES DUE TO THE DISCORDANT, FALSELY ELEVATED ADVIA CENTAUR XP ENHANCED ESTRADIOL (EE2) RESULTS.

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 12176466 ↗
• MalfunctionSep 22, 2020High Test Results; High Test Results

  A DISCORDANT, FALSELY ELEVATED ADVIA CENTAUR XP ENHANCED ESTRADIOL (EE2) RESULT WAS OBTAINED ON A PATIENT SAMPLE. THE RESULT WAS REPORTED TO THE PHYSICIAN AND QUESTIONED. A LOWER RESULT WAS EXPECTED BY THE PHYSICIAN DUE TO ADMINISTERED MEDICATION. THE CUSTOMER SENT THE SAMPLE TO AN ALTERNATE LABORATORY WITH AN ALTERNATE ESTRADIOL TEST METHOD, RESULTING LOWER. THE LOWER ALTERNATE ESTRADIOL TEST RESULT WAS ACCEPTED BY THE PHYSICIAN. THERE ARE NO REPORTS THAT TREATMENT WAS ALTERED, PRESCRIBED, OR ADVERSE HEALTH CONSEQUENCES DUE TO THE DISCORDANT, FALSELY ELEVATED ADVIA CENTAUR XP ENHANCED ESTRADIOL (EE2) RESULT.

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 10570805 ↗
• MalfunctionMay 24, 2019No Apparent Adverse Event; No Apparent Adverse Event

  A FALSE HIGH ADVIA CENTAUR XP ENHANCED ESTRADIOL (EE2) RESULT WAS OBTAINED ON A PATIENT SAMPLE. THE RESULT WAS REPORTED TO THE PHYSICIAN. THE PHYSICIAN QUESTIONED THE RESULT. THE PHYSICIAN SUGGESTED THAT THE SAMPLE BE SENT TO AN ALTERNATE SITE AND TESTED WITH LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY ((LC-MS). THE LC-MS TESTING YIELDED THE EXPECTED RESULT. THE PATIENT HAD A PREVIOUS HIGH ADVIA CENTAUR XP ENHANCED ESTRADIOL (EE2) RESULT THAT WAS NOT QUESTIONED. PATIENT IS TAKING FASLODEX. PATIENT TREATMENT WAS NOT PRESCRIBED OR ALTERED. THERE WAS NO REPORT OF ADVERSE HEALTH CONSEQUENCES AS A RESULT OF THESE DISCORDANT ENHANCED ESTRADIOL RESULTS.

  Patient problems: No Known Impact Or Consequence To Patient

  MAUDE report 8639896 ↗
• MalfunctionMay 24, 2019No Apparent Adverse Event; No Apparent Adverse Event

  A FALSE HIGH ADVIA CENTAUR XP ENHANCED ESTRADIOL (EE2) RESULT WAS OBTAINED ON A PATIENT SAMPLE. THE RESULT WAS REPORTED TO THE PHYSICIAN. THE PHYSICAN QUESTIONED THE RESULT. THE PHYSICIAN SUGGESTED THAT THE SAMPLE BE SENT TO AN ALTERNATE SITE AND TESTED WITH LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY ((LC-MS). THE LC-MS TESTING YIELDED THE EXPECTED RESULT. THE PATIENT HAD A PREVIOUS HIGH ADVIA CENTAUR XP ENHANCED ESTRADIOL (EE2) RESULT THAT WAS NOT QUESTIONED. PATIENT IS TAKING FASLODEX. PATIENT TREATMENT WAS NOT PRESCRIBED OR ALTERED. THERE WAS NO REPORT OF ADVERSE HEALTH CONSEQUENCES AS A RESULT OF THESE DISCORDANT ENHANCED ESTRADIOL RESULTS.

  Patient problems: No Known Impact Or Consequence To Patient

  MAUDE report 8639895 ↗
• MalfunctionApr 19, 2019No Apparent Adverse Event; No Apparent Adverse Event

  A CUSTOMER REPORTED THAT A PATIENT SAMPLE RESULTED HIGHER THAN EXPECTED WHEN TESTED WITH THE ADVIA CENTAUR XPT ENHANCED ESTRADIOL (EE2) ASSAY. INITIAL RESULT WAS QUESTIONED BY THE PHYSICIAN. THE SAMPLE WAS REPEATED WITH A SIMILAR RESULT. THERE ARE NO REPORTS THAT TREATMENT WAS ALTERED OR PRESCRIBED OR ADVERSE HEALTH CONSEQUENCES DUE TO THE ELEVATED ADVIA CENTAUR XPT EE2 RESULTS.

  Patient problems: No Known Impact Or Consequence To Patient

  MAUDE report 8531183 ↗
• MalfunctionApr 19, 2019No Apparent Adverse Event; No Apparent Adverse Event

  A CUSTOMER REPORTED THAT A PATIENT SAMPLE RESULTED HIGHER THAN EXPECTED WHEN TESTED WITH THE ADVIA CENTAUR XPT ENHANCED ESTRADIOL (EE2) ASSAY. INITIAL RESULT WAS QUESTIONED BY THE PHYSICIAN. THE SAMPLE WAS REPEATED WITH A SIMILAR RESULT. THERE ARE NO REPORTS THAT TREATMENT WAS ALTERED OR PRESCRIBED OR ADVERSE HEALTH CONSEQUENCES DUE TO THE ELEVATED ADVIA CENTAUR XPT EE2 RESULTS.

  Patient problems: No Known Impact Or Consequence To Patient

  MAUDE report 8531182 ↗
• MalfunctionOct 9, 2018Adverse Event Without Identified Device or Use Problem; No Apparent Adverse Event; Adverse Event Without Identified Device or Use Problem; No Apparent Adverse Event

  FALSELY ELEVATED ADVIA CENTAUR XPT ENHANCED ESTRADIOL (EE2) PATIENT RESULTS WERE OBSERVED BY THE CUSTOMER, AND THE RESULTS WERE QUESTIONED BY THE PHYSICIAN. THE ELEVATED RESULTS DID NOT FIT PRE-TESTING RESULTS, AND THE SAME PATIENT SAMPLE WAS RUN ON AN ALTERNATE ESTRADIOL TEST METHOD AT ANOTHER LABORATORY. THE ESTRADIOL RESULT WAS LOWER. THERE ARE NO REPORTS THAT TREATMENT WAS ALTERED OR PRESCRIBED OR ADVERSE HEALTH CONSEQUENCES DUE TO THE FALSELY ELEVATED ADVIA CENTAUR XPT ENHANCED ESTRADIOL (EE2) RESULT. MDR 1219913-2017-00249 WAS FILED FOR THE SAME PATIENT FOR INITIAL TESTING PERFORMED ON A DIFFERENT DAY.

  Patient problems: No Known Impact Or Consequence To Patient

  MAUDE report 7947129 ↗
• MalfunctionOct 9, 2018Adverse Event Without Identified Device or Use Problem; No Apparent Adverse Event; Adverse Event Without Identified Device or Use Problem; No Apparent Adverse Event

  FALSELY ELEVATED ADVIA CENTAUR XPT ENHANCED ESTRADIOL (EE2) PATIENT RESULTS WERE OBSERVED BY THE CUSTOMER, AND THE RESULTS WERE QUESTIONED BY THE PHYSICIAN. THE ELEVATED RESULTS DID NOT FIT PRE-TESTING RESULTS, AND THE SAME PATIENT SAMPLE WAS RUN ON AN ALTERNATE ESTRADIOL TEST METHOD AT ANOTHER LABORATORY. THE ESTRADIOL RESULT WAS LOWER. THERE ARE NO REPORTS THAT TREATMENT WAS ALTERED OR PRESCRIBED OR ADVERSE HEALTH CONSEQUENCES DUE TO THE FALSELY ELEVATED ADVIA CENTAUR XPT ENHANCED ESTRADIOL (EE2) RESULT. MDR 1219913-2017-00252 WAS FILED FOR THE SAME PATIENT FOR TESTING PERFORMED ON A DIFFERENT DAY.

  Patient problems: No Known Impact Or Consequence To Patient

  MAUDE report 7947047 ↗
• MalfunctionSep 13, 2018No Apparent Adverse Event; No Apparent Adverse Event

  CUSTOMER OBSERVED ELEVATED ADVIA CENTAUR XP ENHANCED ESTRADIOL RESULTS FOR THREE SAMPLES FROM THE SAME PATIENT COMPARED TO CLINICAL EXPECTATIONS AND AN ALTERNATE METHOD. THERE ARE NO REPORTS THAT TREATMENT WAS ALTERED OR PRESCRIBED OR ADVERSE HEALTH CONSEQUENCES DUE TO THE ELEVATED ADVIA CENTAUR XP ENHANCED ESTRADIOL RESULTS.

  Patient problems: No Known Impact Or Consequence To Patient

  MAUDE report 7872351 ↗
• MalfunctionSep 13, 2018No Apparent Adverse Event; No Apparent Adverse Event

  CUSTOMER OBSERVED ELEVATED ADVIA CENTAUR XP ENHANCED ESTRADIOL RESULTS FOR THREE SAMPLES FROM THE SAME PATIENT COMPARED TO CLINICAL EXPECTATIONS AND AN ALTERNATE METHOD. THERE ARE NO REPORTS THAT TREATMENT WAS ALTERED OR PRESCRIBED OR ADVERSE HEALTH CONSEQUENCES DUE TO THE ELEVATED ADVIA CENTAUR XP ENHANCED ESTRADIOL RESULTS.

  Patient problems: No Known Impact Or Consequence To Patient

  MAUDE report 7872342 ↗
• MalfunctionSep 13, 2018No Apparent Adverse Event; No Apparent Adverse Event

  CUSTOMER OBSERVED ELEVATED ADVIA CENTAUR XP ENHANCED ESTRADIOL RESULTS FOR THREE SAMPLES FROM THE SAME PATIENT COMPARED TO CLINICAL EXPECTATIONS AND AN ALTERNATE METHOD. THERE ARE NO REPORTS THAT TREATMENT WAS ALTERED OR PRESCRIBED OR ADVERSE HEALTH CONSEQUENCES DUE TO THE ELEVATED ADVIA CENTAUR XP ENHANCED ESTRADIOL RESULTS.

  Patient problems: No Known Impact Or Consequence To Patient

  MAUDE report 7872338 ↗
• MalfunctionSep 13, 2018No Apparent Adverse Event; No Apparent Adverse Event

  CUSTOMER OBSERVED ELEVATED ADVIA CENTAUR XP ENHANCED ESTRADIOL RESULTS FOR THREE SAMPLES FROM THE SAME PATIENT COMPARED TO CLINICAL EXPECTATIONS AND AN ALTERNATE METHOD. THERE ARE NO REPORTS THAT TREATMENT WAS ALTERED OR PRESCRIBED OR ADVERSE HEALTH CONSEQUENCES DUE TO THE ELEVATED ADVIA CENTAUR XP ENHANCED ESTRADIOL RESULTS.

  Patient problems: No Known Impact Or Consequence To Patient

  MAUDE report 7872337 ↗
• MalfunctionAug 14, 2018No Apparent Adverse Event; No Apparent Adverse Event

  A FALSE HIGH ADVIA CENTAUR XP ENHANCED ESTRADIOL (EE2) RESULT WAS OBTAINED ON A PATIENT SAMPLE. THE RESULT WAS REPORTED TO THE PHYSICIAN. THE PHYSICIAN QUESTIONED THE RESULT AFTER A REDRAW SAMPLE WAS TESTED IN ANOTHER LABORATORY WITH THE ELECTROCHEMILUMINESCENCE METHOD AND THE RESULT WAS LOW. AFTER THE RESULT WAS QUESTIONED, THE LABORATORY REPEATED THE SAMPLE AGAIN AND THE RESULT WAS ELEVATED. THE PATIENT SAMPLE WAS SENT TO A LABORATORY OF SUPPORT AND TESTED. THE RESULT WAS LOW. THE PATIENT IS MENOPAUSAL. PATIENT TREATMENT WAS NOT PRESCRIBED OR ALTERED. THERE WAS NO REPORT OF ADVERSE HEALTH CONSEQUENCES AS A RESULT OF THESE DISCORDANT ENHANCED ESTRADIOL RESULTS.

  Patient problems: No Known Impact Or Consequence To Patient

  MAUDE report 7781970 ↗

Other Siemens Healthcare Diagnostics Inc. products

• Atellica IM TNIH2 models · 629 reports
• Dimension EXL 200 Integrated Chemistry System2 models · 516 reports · 1 recall
• Atellica IM CA 19-93 models · 121 reports · 3 recalls
• ADVIA Centaur XP Analyzer2 models · 269 reports
• ADVIA Centaur CA 19-92 models · 124 reports · 2 recalls
• Atellica IM eE23 models · 65 reports · 3 recalls
• RAPIDPoint 500 Measurement Cartridge4 models · 3 reports · 4 recalls
• Atellica IM Fol3 models · 10 reports · 3 recalls